Ryan J. Sullivan

1Massachusetts General Hospital, Boston, MA;

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 81 papers. Top paper: “The Lipogenic Regulator SREBP2 Induces Transferrin in Circulating Melanoma Cells and Suppresses Ferroptosis”.

The Lipogenic Regulator SREBP2 Induces Transferrin in Circulating Melanoma Cells and Suppresses Ferroptosis

Cancer Discovery(2020)10.1158/2159-8290.cd-19-1500

N/A

6.3DataRank · unranked

231 citations

Whijae Roh, Ryan J. Sullivan, Keith H.K. Wong, Ben S. Wittner, Hongshan Guo +24 more

Evolution of delayed resistance to immunotherapy in a melanoma responder

Nature Medicine(2021)10.1038/s41591-021-01331-8

N/A

3.6DataRank · unranked

137 citations

Jia‐Ren Lin, Emily Robitschek, Gyulnara G. Kasumova, Alex Heyde, Alvin Shi +35 more

A multicenter characterization of hepatitis associated with immune checkpoint inhibitors

OncoImmunology(2021)10.1080/2162402x.2021.1875639

N/A

2.2DataRank · unranked

63 citations

Ben McGuigan, Sunandana Chandra, Sarah E. Fenton, Akansha Chowdhary, Lucy Boyce Kennedy +14 more

Plasma-derived extracellular vesicle analysis and deconvolution enable prediction and tracking of melanoma checkpoint blockade outcome

Science Advances(2020)10.1126/sciadv.abb3461

N/A

2.0DataRank · unranked

60 citations

Gyulnara G. Kasumova, William A. Michaud, Jessica Cintolo-Gonzalez, Marta Díaz-Martínez, Jacqueline Ohmura +13 more

Microenvironmental Landscape of Human Melanoma Brain Metastases in Response to Immune Checkpoint Inhibition

Cancer Immunology Research(2022)10.1158/2326-6066.cir-21-0870

N/A

1.6DataRank · unranked

53 citations

Samuel C. Markson, Jackson H. Stocking, Naema Nayyar, Matt Lastrapes, Matthew R. Strickland +40 more

Pembrolizumab in brain metastases of diverse histologies: phase 2 trial results

Nature Medicine(2023)10.1038/s41591-023-02392-7

N/A

1.6DataRank · unranked

66 citations

Albert E. Kim, Anita Giobbie‐Hurder, Eudocia Q. Lee, Nancy U. Lin, Beth Overmoyer +28 more

Efficacy and Safety of Trametinib in Non-V600 BRAF Mutant Melanoma: A Phase II Study

The Oncologist(2021)10.1002/onco.13795

N/A

1.5DataRank · unranked

43 citations

Douglas B. Johnson, Ryan J. Sullivan, R. Amaria, Keith T. Flaherty, Jeffrey A. Sosman +2 more

Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq

Science(2016)10.1126/science.aad0501

N/A

1.3DataRank · unranked

5121 citations

Benjamin Izar, Sanjay M. Prakadan, Marc H. Wadsworth, Daniel Treacy, John J. Trombetta +39 more

Characterization and management of ERK inhibitor associated dermatologic adverse events: analysis from a nonrandomized trial of ulixertinib for advanced cancers

Investigational New Drugs(2021)10.1007/s10637-020-01035-9

N/A

1.2DataRank · unranked

32 citations

D. Liu, Michael Offin, Cecilia Lezcano, Jean Torrisi, Sheldon L. Brownstein +13 more

Combined tumor and immune signals from genomes or transcriptomes predict outcomes of checkpoint inhibition in melanoma

Cell Reports Medicine(2022)10.1016/j.xcrm.2021.100500

N/A

0.972DataRank · unranked

35 citations

Moshe Sade-Feldman, Jaegil Kim, Chip Stewart, Anna Gonye, Arvind Ravi +34 more

Microenvironment drives cell state, plasticity, and drug response in pancreatic cancer

Cell(2021)10.1016/j.cell.2021.11.017

N/A

0.959DataRank · unranked

597 citations

Peter Winter, Andrew W. Navia, Hannah L. Williams, Alan DenAdel, Kristen E. Lowder +42 more

Molecular Pathways of Colon Inflammation Induced by Cancer Immunotherapy

Cell(2020)10.1016/j.cell.2020.06.001

N/A

0.927DataRank · unranked

481 citations

Shengbao Suo, Hannah L. Williams, Tatyana Sharova, Keri M. Sullivan, Michael P. Manos +11 more

Implementation and Clinical Adoption of Precision Oncology Workflows Across a Healthcare Network

The Oncologist(2022)10.1093/oncolo/oyac134

N/A

0.867DataRank · unranked

22 citations

Rebecca S. Heist, Adam Z. Bard, Annacarolina F L da Silva, Ibiayi Dagogo‐Jack, Valentina Nardi +45 more

Phase 1 Clinical Trial Evaluating the Safety and Anti-Tumor Activity of ADP-A2M10 SPEAR T-Cells in Patients With MAGE-A10+ Head and Neck, Melanoma, or Urothelial Tumors

Frontiers in Oncology(2022)10.3389/fonc.2022.818679

N/A

0.830DataRank · unranked

20 citations

Marcus O. Butler, Russell K. Pachynski, Ryan J. Sullivan, Partow Kebriaei, Sarah Boross-Harmer +20 more

The State of Melanoma: Emergent Challenges and Opportunities

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-20-4092

N/A

0.705DataRank · unranked

109 citations

Clara Curiel‐Lewandrowski, David E. Fisher, Susan M. Swetter, Hensin Tsao, Julio A. Aguirre‐Ghiso +31 more

FGFR2 Extracellular Domain In-Frame Deletions Are Therapeutically Targetable Genomic Alterations That Function as Oncogenic Drivers in Cholangiocarcinoma

Cancer Discovery(2021)10.1158/2159-8290.cd-20-1669

N/A

0.705DataRank · unranked

109 citations

Srivatsan Raghavan, Qibiao Wu, Yvonne Y. Li, Liam F. Spurr, Hersh Gupta +35 more

Eganelisib, a First-in-Class PI3Kγ Inhibitor, in Patients with Advanced Solid Tumors: Results of the Phase 1/1b MARIO-1 Trial

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-22-3313

N/A

0.659DataRank · unranked

80 citations

Michael A. Postow, Bartosz Chmielowski, Ryan J. Sullivan, Amita Patnaik, Ezra E.W. Cohen +12 more

Mucosal inflammation predicts response to systemic steroids in immune checkpoint inhibitor colitis

Journal for ImmunoTherapy of Cancer(2020)10.1136/jitc-2019-000451

N/A

0.650DataRank · unranked

75 citations

Daniel Wang, Alexandra Coromilas, Melissa Lumish, Tianqi Chen, Anita Giobbie‐Hurder +4 more

Decreased Absolute Lymphocyte Count and Increased Neutrophil/Lymphocyte Ratio With Immune Checkpoint Inhibitor–Associated Myocarditis

Journal of the American Heart Association(2020)10.1161/jaha.120.018306

N/A

0.646DataRank · unranked

73 citations

Amna Zafar, Leyre Zubiri, Daniel A. Zlotoff, Raza M. Alvi, Charlotte Lee +10 more

Genomic and transcriptomic correlates of immunotherapy response within the tumor microenvironment of leptomeningeal metastases

Nature Communications(2021)10.1038/s41467-021-25860-5

N/A

0.637DataRank · unranked

69 citations

Christopher Alvarez‐Breckenridge, Samuel C. Markson, Albert E. Kim, Robert H. Klein, Naema Nayyar +24 more

Immune checkpoint inhibitors in patients with pre-existing psoriasis: safety and efficacy

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2021-003066

N/A

0.628DataRank · unranked

65 citations

Allison Betof Warner, Farzana Y. Zaman, Andrew Haydon, Prachi Bhave, Anna K. Dewan +20 more

Immune Responses in Checkpoint Myocarditis Across Heart, Blood, and Tumor

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.09.15.557794

N/A

0.607DataRank · unranked

12 citations

Daniel A. Zlotoff, Neal P. Smith, Isabela Kernin, Swetha Ramesh, Leyre Zubiri +31 more

Pathway signatures derived from on-treatment tumor specimens predict response to anti-PD1 blockade in metastatic melanoma

Nature Communications(2021)10.1038/s41467-021-26299-4

N/A

0.593DataRank · unranked

51 citations

Shiyou Wei, Zhi Wei, Dennie T. Frederick, Benchun Miao, Tabea Moll +10 more

Phase I/II Study of Combined BCL-xL and MEK Inhibition with Navitoclax and Trametinib in KRAS or NRAS Mutant Advanced Solid Tumors

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-23-3135

N/A

0.546DataRank · unranked

37 citations

T. Khanh, Jeong Eun Kim, James M. Cleary, Aparna R. Parikh, Oladapo Yeku +26 more

Defining D-irAEs: consensus-based disease definitions for the diagnosis of dermatologic adverse events from immune checkpoint inhibitor therapy

Journal for ImmunoTherapy of Cancer(2024)10.1136/jitc-2023-007675

N/A

0.500DataRank · unranked

27 citations

Yevgeniy R. Semenov, Allireza Alloo, Daniel Q. Bach, Allison Betof Warner, Amina Bougrine +36 more

Mature and migratory dendritic cells promote immune infiltration and response to anti-PD-1 checkpoint blockade in metastatic melanoma

Nature Communications(2025)10.1038/s41467-025-62878-5

N/A

0.438DataRank · unranked

13 citations

Cassia Wang, Doris Fu, Marcus Ho, Kyriakitsa Galani, Lee Chen +21 more

Downregulation of KEAP1 in melanoma promotes resistance to immune checkpoint blockade

npj Precision Oncology(2023)10.1038/s41698-023-00362-3

N/A

0.434DataRank · unranked

17 citations

Richard Y. Ebright, Xin Hong, Hunter C. Russell, Hongshan Guo, Thomas J. LaSalle +11 more

Overcoming resistance to immunotherapy by targeting CD38 in human tumor explants

Cell Reports Medicine(2025)10.1016/j.xcrm.2025.102210

N/A

0.382DataRank · unranked

9 citations

Angelina M. Cicerchia, Ofir Shorer, Claire A. Palin, Boryana Petrova, Seth Anderson +50 more

Combined tumor and immune signals from genomes or transcriptomes predict outcomes of checkpoint inhibition in melanoma

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.07.03.450733

N/A

0.358DataRank · unranked

7 citations

Moshe Sade-Feldman, Jaegil Kim, Chip Stewart, Anna Gonye, Arvind Ravi +34 more

Characterizing the tumor and immune landscape of melanoma patients treated with combined checkpoint blockade and MAPK targeted therapy.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.9522

N/A

0.326DataRank · unranked

3 citations

Donald P. Lawrence, David F. McDermott, Mofei Liu, Elizabeth I. Buchbinder, Irena Gushterova +14 more

Abnormal vascular structure and function within brain metastases is linked to pembrolizumab resistance

Neuro-Oncology(2023)10.1093/neuonc/noad236

N/A

0.323DataRank · unranked

6 citations

Kevin W Lou, Anita Giobbie‐Hurder, Ken Chang, Mishka Gidwani, Katharina Hoebel +38 more

Tumor location as a risk factor for severe immune-related adverse events

Journal for ImmunoTherapy of Cancer(2025)10.1136/jitc-2024-011312

N/A

0.312DataRank · unranked

7 citations

Ben Ouyang, Leyre Zubiri, Daniel Leonard, Kamil Slowikowski, Mike Wang +11 more

CTEP 9557: A dose-escalation trial of combination dabrafenib, trametinib, and AT13387 in patients with BRAF mutant solid tumors.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.3609

N/A

0.293DataRank · unranked

4 citations

James M. Cleary, Justine V. Cohen, Donald P. Lawrence, Elizabeth I. Buchbinder, Anita Giobbie‐Hurder +11 more

Musculoskeletal ultrasound characteristics of checkpoint inhibitor-associated inflammatory arthritis

Seminars in Arthritis and Rheumatism(2024)10.1016/j.semarthrit.2024.152573

N/A

0.292DataRank · unranked

6 citations

Gregory J. Challener, Sara Schoenfeld, Mark Matza, Donald P. Lawrence, Meghan J. Mooradian +4 more

Long-term outcomes of chronic immune-related adverse events from adjuvant anti-PD-1 therapy for high-risk resected melanoma.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.9591

N/A

0.292DataRank · unranked

6 citations

Aleigha Lawless, Rachel Woodford, Faisal Fa’ak, Asha Tipirneni, James R. Patrinely +11 more

Disrupting CD38-driven T cell dysfunction restores sensitivity to cancer immunotherapy

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.02.12.579184

N/A

0.290DataRank · unranked

5 citations

Angelina M. Cicerchia, Ofir Shorer, Boryana Petrova, Seth Anderson, Joshua Park +48 more

Plasma proteomic biomarkers identify non-responders and reveal biological insights about the tumor microenvironment in melanoma patients after PD1 blockade

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.02.02.478819

N/A

0.269DataRank · unranked

5 citations

Marijana Ručević, Emmett Sprecher, Milan Parikh, Jiajia Chen, Dennie T. Frederick +23 more

Randomized phase II trial of dabrafenib and trametinib with or without navitoclax in patients (pts) with BRAF-mutant (MT) metastatic melanoma (MM) (CTEP P9466).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.9511

N/A

0.239DataRank · unranked

3 citations

Janice M. Mehnert, Anita Giobbie‐Hurder, Kari Kendra, Gino K. In, April K.S. Salama +14 more

Plasma-derived exosomal analysis and deconvolution enables prediction and tracking of melanoma checkpoint blockade response

bioRxiv (Cold Spring Harbor Laboratory)(2019)10.1101/809699

N/A

0.219DataRank · unranked

2 citations

Gyulnara G. Kasumova, William A. Michaud, Jessica Cintolo-Gonzales, Marta Díaz Martínez, Jacqueline Ohmura +12 more

Immune Checkpoint Inhibitors, Atherosclerotic Cardiovascular Events, and Plaque Progression Among Women With Cancer

Journal of the American Heart Association(2025)10.1161/jaha.125.041925

N/A

0.208DataRank · unranked

3 citations

Zsófia D. Drobni, Carlos A. Gongora, Jana Taron, Júlia Karády, Hannah Gilman +10 more

Single-cell profiling of human heart and blood in immune checkpoint inhibitor-associated myocarditis.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.2507

N/A

0.165DataRank · unranked

2 citations

Daniel A. Zlotoff, Neal P. Smith, Swetha Ramesh, Isabela Kernin, Pritha Sen +15 more

Targeting AMP kinase in melanoma: A phase I trial of phenformin with dabrafenib/trametinib.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.9536

N/A

0.115DataRank · unranked

1 citations

Mark Klang, Michael A. Postow, Alexander N. Shoushtari, Ryan J. Sullivan, Jedd D. Wolchok +4 more

Phylogenetic analysis of longitudinal melanoma samples to reveal convergent evolution and markers of immunotherapy resistance.

Journal of Clinical Oncology(2018)10.1200/jco.2018.36.15_suppl.9581

N/A

0.104DataRank · unranked

1 citations

Gao Zhang, Alvin Shi, Benjamin Izar, Alexander Heyde, Gyulnara G. Kasumova +14 more

International real-world study of combination immunotherapy sequences in metastatic melanoma

Journal for ImmunoTherapy of Cancer(2025)10.1136/jitc-2025-012225

N/A

0DataRank · unranked

0 citations

Sarah E. Lochrin, James W. Smithy, Michael A. Postow, Caroline Gaudy‐Marqueste, Nausicaa Malissen +28 more

Melanoma to rhabdomyosarcoma plasticity in the setting of immunotherapy

(2025)10.1101/2025.10.31.25338685

N/A

0DataRank · unranked

0 citations

Dennie T. Frederick, Alvin Shi, Ana B. Larque, Benchun Miao, Tatyana Sharova +16 more

Cardiovascular magnetic resonance in immune checkpoint inhibitor-associated myocarditis

European Heart Journal(2020)10.1093/eurheartj/ehaa051

N/A

0DataRank · unranked

345 citations

Magid Awadalla, Syed Mahmood, Anju Nohria, Malek Hassan, Franck Thuny +39 more

Global Longitudinal Strain and Cardiac Events in Patients With Immune Checkpoint Inhibitor-Related Myocarditis

Journal of the American College of Cardiology(2020)10.1016/j.jacc.2019.11.049

N/A

0DataRank · unranked

285 citations

Syed Mahmood, John D. Groarke, Malek Hassan, Anju Nohria, Adam Rokicki +37 more

Immune checkpoint inhibitor toxicities: systems-based approaches to improve patient care and research

The Lancet Oncology(2020)10.1016/s1470-2045(20)30107-8

N/A

0DataRank · unranked

110 citations

Kerry L. Reynolds, Ryan J. Sullivan, Justin M. Balko, James R. Patrinely, Laura C. Cappelli +3 more

Targeting Extracellular Matrix Remodeling Restores BRAF Inhibitor Sensitivity in BRAFi-resistant Melanoma

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-19-2773

N/A

0DataRank · unranked

45 citations

Varsha Thakur, Yuan Li, Juliano T. Freitas, Patrick M. Zmina, Vijay S. Thakur +16 more

Emerging Immunotherapies in the Treatment of Brain Metastases

The Oncologist(2020)10.1002/onco.13575

N/A

0DataRank · unranked

47 citations

Naema Nayyar, Mohini Singh, Ryan J. Sullivan, Priscilla K. Brastianos, Edwin Nieblas‐Bedolla

Clinical features of acute kidney injury in patients receiving dabrafenib and trametinib

Nephrology Dialysis Transplantation(2020)10.1093/ndt/gfaa372

N/A

0DataRank · unranked

22 citations

Meghan Lee, Ian A. Strohbehn, Orhan Efe, Nifasha Rusibamayila, Donald F. Chute +9 more

Acute Kidney Injury Following Encorafenib and Binimetinib for Metastatic Melanoma

Kidney Medicine(2020)10.1016/j.xkme.2020.01.012

N/A

0DataRank · unranked

9 citations

Halla Bates, Donald F. Chute, Ian A. Strohbehn, Samuel Strohbehn, Riley Fadden +5 more

Advanced imaging to assess longitudinal vascular changes in brain metastases treated with immune checkpoint inhibition.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.2529

N/A

0DataRank · unranked

0 citations

Ken Chang, Andrew Beers, Kyrre E. Emblem, Jayashree Kalpathy–Cramer, Eudocia Q. Lee +15 more

Investigating the tumor immune infiltrate for populations that predict immune-related adverse events (irAEs) in patients receiving PD-1 inhibitors.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.3116

N/A

0DataRank · unranked

0 citations

Neal P. Smith, Moshe Sade-Feldman, Dennie T. Frederick, Russell W. Jenkins, Justine V. Cohen +13 more

Chronic Immune-Related Adverse Events Following Adjuvant Anti–PD-1 Therapy for High-risk Resected Melanoma

JAMA Oncology(2021)10.1001/jamaoncol.2021.0051

N/A

0DataRank · unranked

254 citations

Rebecca Johnson, Aleigha Lawless, Prachi Bhave, Amelia Sawyers, Maya Dimitrova +15 more

Myocardial T1 and T2 Mapping by Magnetic Resonance in Patients With Immune Checkpoint Inhibitor–Associated Myocarditis

Journal of the American College of Cardiology(2021)10.1016/j.jacc.2021.01.050

N/A

0DataRank · unranked

189 citations

Lili Zhang, Amna Zafar, Zsófia D. Drobni, Syed Mahmood, Marcella Cabral +40 more

Immunogenicity and Reactogenicity of SARS-CoV-2 Vaccines in Patients With Cancer: The CANVAX Cohort Study

Journal of Clinical Oncology(2021)10.1200/jco.21.01891

N/A

0DataRank · unranked

94 citations

Claire A. Pernat, Alexander Gavralidis, Kerri St. Denis, Evan C. Lam, Laura M. Spring +41 more

Pericardial disease in patients treated with immune checkpoint inhibitors

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2021-002771

N/A

0DataRank · unranked

84 citations

Zsófia D. Drobni, Amna Zafar, Thiago Quinaglia, Sarah Hartmann, Hannah Gilman +11 more

Electrocardiographic features of immune checkpoint inhibitor associated myocarditis

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2020-002007

N/A

0DataRank · unranked

78 citations

Malek Hassan, Amna Zafar, Raza M. Alvi, Magid Awadalla, Syed Mahmood +35 more

Immune checkpoint inhibitors for cancer and venous thromboembolic events

European Journal of Cancer(2021)10.1016/j.ejca.2021.09.010

N/A

0DataRank · unranked

78 citations

Zsófia D. Drobni, Raza M. Alvi, Sean Murphy, Ryan J. Sullivan, Sarah Hartmann +11 more

Absolute quantification of tumor antigens using embedded MHC-I isotopologue calibrants

Proceedings of the National Academy of Sciences(2021)10.1073/pnas.2111173118

N/A

0DataRank · unranked

52 citations

Aaron S. Gajadhar, Bhavin Patel, Sébastien Gallien, Dennie T. Frederick, Genevieve M. Boland +3 more

The positive effect of immune checkpoint inhibitor-induced thyroiditis on overall survival accounting for immortal time bias: a retrospective cohort study of 6596 patients

Annals of Oncology(2021)10.1016/j.annonc.2021.05.357

N/A

0DataRank · unranked

41 citations

Donald F. Chute, Ian A. Strohbehn, Sophia Zhao, Michelle Rengarajan, Alexander T. Faje +13 more

Association between incidental statin use and skeletal myopathies in patients treated with immune checkpoint inhibitors

Immunotherapy Advances(2021)10.1093/immadv/ltab014

N/A

0DataRank · unranked

22 citations

Sean Murphy, Raza M. Alvi, Charlotte Lee, Jingyi Gong, Ramya Mosarla +14 more

Rejection of benign melanocytic nevi by nevus-resident CD4 + T cells

Science Advances(2021)10.1126/sciadv.abg4498

N/A

0DataRank · unranked

14 citations

Scarlett Se Yun Cheon, Seokjin Ham, Heehwa G. Son, Jonathan L. Messerschmidt, Donald P. Lawrence +7 more

Pericardial disease in patients treated with immune checkpoint inhibitors

European Heart Journal(2021)10.1093/eurheartj/ehab724.1833

N/A

0DataRank · unranked

3 citations

Zsófia D. Drobni, Amna Zafar, Thiago Quinaglia, Sylvia Hartmann, Hannah Gilman +10 more

Microenvironmental correlates of immune checkpoint inhibitor response in human melanoma brain metastases revealed by T cell receptor and single-cell RNA sequencing

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.08.25.456956

N/A

0DataRank · unranked

0 citations

Samuel C. Markson, Jackson H. Stocking, Naema Nayyar, Matthew Lastrapes, Matthew R. Strickland +39 more

Renin–angiotensin–aldosterone system inhibitors and survival in patients with hypertension treated with immune checkpoint inhibitors

European Journal of Cancer(2022)10.1016/j.ejca.2021.12.024

N/A

0DataRank · unranked

45 citations

Olivier Michielin, Thiago Quinaglia, Daniel A. Zlotoff, Leyre Zubiri, Hannah Gilman +9 more

Pre-Existing Autoimmune Disease Increases the Risk of Cardiovascular and Noncardiovascular Events After Immunotherapy

JACC CardioOncology(2022)10.1016/j.jaccao.2022.11.008

N/A

0DataRank · unranked

43 citations

Zsófia D. Drobni, Amna Zafar, Carlos A. Gongora, Daniel A. Zlotoff, Raza M. Alvi +16 more

STAG2 regulates interferon signaling in melanoma via enhancer loop reprogramming

Nature Communications(2022)10.1038/s41467-022-29541-9

N/A

0DataRank · unranked

45 citations

Lei Gu, Yeguang Hu, Xiaoyang Zhang, Man Li, Jiajia Chen +20 more

Phase II Study of Cabozantinib in Patients With Bone Metastasis

The Oncologist(2022)10.1093/oncolo/oyac083

N/A

0DataRank · unranked

9 citations

Gregory A. Coté, M. Dror Michaelson, Lori J. Wirth, Justin F. Gainor, Alona Muzikansky +6 more

The impact of stage-related features in melanoma recurrence prediction: A machine learning approach

JAAD International(2022)10.1016/j.jdin.2022.08.014

N/A

0DataRank · unranked

3 citations

Bonnie W. Leung, Nga Nguyen, Mia S. DeSimone, Feng Liu, Min Seok Choi +13 more

Effect of Cancer Stage on Adverse Kidney Outcomes in Patients Receiving Immune Checkpoint Inhibitors for Melanoma

Kidney International Reports(2022)10.1016/j.ekir.2022.08.030

N/A

0DataRank · unranked

4 citations

Ian A. Strohbehn, Sophia Zhao, Harish Seethapathy, Samuel D. Strohbehn, Paul Hanna +7 more

Soluble and cell-based markers of immune checkpoint inhibitor associated nephritis

medRxiv(2022)10.1101/2022.10.13.22280966

N/A

0DataRank · unranked

3 citations

Qiyu Wang, Harish Seethapathy, Daiana Moreno, Destiny Harden, R. Neal Smith +13 more

Clinical activity of MAPK targeted therapies in patients with non-V600 BRAF mutant tumors

medRxiv(2022)10.1101/2022.02.17.22271120

N/A

0DataRank · unranked

1 citations

Yifan Wang, Rouhi Fazelzad, Benny Johnson, Caroline A. Nebhan, Ibiayi Dagogo‐Jack +24 more

Perspectives in Immunotherapy: meeting report from Immunotherapy Bridge (Naples, November 30th–December 1st, 2022)

Journal of Translational Medicine(2023)10.1186/s12967-023-04329-7

N/A

0DataRank · unranked

11 citations

Antonio Avallone, Carlo Bifulco, Sergio Bracarda, Joshua Brody, Leisha A. Emens +19 more

664P Final results of a phase I/II study of combined BCL-xL and MEK inhibition with navitoclax and trametinib in KRAS or NRAS mutant advanced solid tumors

Annals of Oncology(2023)10.1016/j.annonc.2023.09.1850

N/A

0DataRank · unranked

1 citations

T. Khanh, James M. Cleary, Aparna R. Parikh, Oladapo Yeku, Colin D. Weekes +13 more

Structural and functional vascular dysfunction within brain metastases is linked to pembrolizumab inefficacy

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.08.25.554868

N/A

0DataRank · unranked

0 citations

Kevin W Lou, Anita Giobbie‐Hurder, Ken Chang, Mishka Gidwani, Katharina Hoebel +38 more

Overcoming Resistance Mechanisms to Melanoma Immunotherapy

American Journal of Clinical Dermatology(2024)10.1007/s40257-024-00907-7

N/A

0DataRank · unranked

19 citations

David J. Bozym, Giuseppe Tarantino, Ryan J. Sullivan, David Liu, Russell W. Jenkins +1 more

Predicting Recurrence-Free and Overall Survival for Patients With Stage II Melanoma: The MIA Calculator

Journal of Clinical Oncology(2024)10.1200/jco.23.01020

N/A

0DataRank · unranked

16 citations

Isabel Li, Mary‐Ann El Sharouni, J. M. Gardner, Aikaterini Dedeilia, Sydney Ch’ng +17 more

Impact of steroid dose and timing on efficacy of combination PD-1/CTLA-4 blockade

OncoImmunology(2025)10.1080/2162402x.2025.2494433

N/A

0DataRank · unranked

15 citations

Rebecca Irlmeier, Xue Bai, Can Cui, Fei Ye, Hannah Burnette +5 more

Factors that increase class I MHC expression may contribute to the development of immune checkpoint inhibitor-induced diabetes

Journal for ImmunoTherapy of Cancer(2025)10.1136/jitc-2025-012358

N/A

0DataRank · unranked

4 citations

Noam Savion‐Gaiger, Ana Luisa Perdigoto, Jacqueline E. Mann, Madeline Candelas Torres, Genevieve M. Boland +12 more